Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Other | 1.5 | | 1.6 | 3.4 | 6.3 | | | |
| Nu Skin | 2,521.0 | 2,431.7 | 2,298.4 | 2,588.4 | | | 1,363.5 | 1,562.6 |
| Other | 173.1 | 150.2 | 120.4 | 87.2 | 2,272.8 | | 883.5 | 1,006.9 |
| Total revenues | 2,695.7 | 2,581.9 | 2,420.4 | 2,679.0 | 2,279.1 | 2,207.8 | 2,247.0 | 2,569.5 |
| Revenue growth [+] | 4.4% | 6.7% | -9.7% | 17.5% | 3.2% | -1.7% | -12.5% | -19.1% |
| Other | | | -52.6% | -45.7% | | | | |
| Nu Skin | 3.7% | 5.8% | -11.2% | | | | -12.7% | -4.8% |
| Pharmanex | | | | | | | -12.2% | -34.6% |
| Cost of goods sold | 675.2 | 658.0 | 581.4 | 634.1 | 502.1 | 500.5 | 489.5 | 478.4 |
| Gross profit | 2,020.4 | 1,923.9 | 1,839.0 | 2,044.9 | 1,777.0 | 1,707.3 | 1,757.5 | 2,091.1 |
| Gross margin | 75.0% | 74.5% | 76.0% | 76.3% | 78.0% | 77.3% | 78.2% | 81.4% |
| Selling, general and administrative [+] | 1,734.6 | 1,666.3 | 1,571.6 | 1,733.3 | 1,502.5 | 1,476.2 | 1,512.8 | 1,738.9 |
| Sales and marketing | 1,068.2 | 1,019.5 | 955.6 | 1,071.0 | 938.0 | 922.1 | 951.4 | 1,116.6 |
| General and administrative | 666.4 | 646.8 | 616.0 | 662.3 | 564.5 | 554.2 | 561.5 | 622.3 |
| EBITDA [+] | 362.2 | 331.6 | 344.1 | 394.5 | 346.0 | 303.5 | 316.1 | 407.1 |
| EBITDA growth | 9.2% | -3.6% | -12.8% | 14.0% | 14.0% | -4.0% | -22.4% | -30.9% |
| EBITDA margin | 13.4% | 12.8% | 14.2% | 14.7% | 15.2% | 13.7% | 14.1% | 15.8% |
| Depreciation | 64.6 | 64.2 | 63.3 | 64.7 | 63.5 | 64.0 | 62.8 | 46.5 |
| EBITA | 297.6 | 267.4 | 280.8 | 329.8 | 282.6 | 239.5 | 253.3 | 360.6 |
| EBITA margin | 11.0% | 10.4% | 11.6% | 12.3% | 12.4% | 10.8% | 11.3% | 14.0% |
| Amortization of intangibles | 11.7 | 9.8 | 13.4 | 18.3 | 8.1 | 8.4 | 8.6 | 8.4 |
| EBIT [+] | 285.9 | 257.6 | 267.4 | 311.5 | 274.5 | 231.1 | 244.7 | 352.2 |
| EBIT growth | 11.0% | -3.7% | -14.2% | 13.5% | 18.8% | -5.6% | -30.5% | -36.4% |
| EBIT margin | 10.6% | 10.0% | 11.0% | 11.6% | 12.0% | 10.5% | 10.9% | 13.7% |
| Non-recurring items | 51.9 | | | 70.7 | | | | |
| Interest expense | | | | | | | 7.0 | |
| Interest expense | 11.0 | 13.1 | 19.2 | 21.8 | 22.2 | 15.6 | 7.0 | 5.7 |
| Other income (expense), net | 9.5 | 11.8 | 6.9 | 0.6 | 13.3 | -2.7 | -25.7 | -48.0 |
| Pre-tax income | 232.5 | 256.2 | 255.2 | 219.7 | 265.6 | 212.8 | 212.0 | 298.5 |
| Income taxes | 85.2 | 64.9 | 81.6 | 97.8 | 136.1 | 69.8 | 78.9 | 109.3 |
| Tax rate | 36.6% | 25.3% | 32.0% | 44.5% | 51.3% | 32.8% | 37.2% | 36.6% |
| Net income | 147.3 | 191.4 | 173.6 | 121.9 | 129.4 | 143.1 | 133.0 | 189.2 |
| Net margin | 5.5% | 7.4% | 7.2% | 4.5% | 5.7% | 6.5% | 5.9% | 7.4% |
| |
| Basic EPS [+] | $2.93 | $3.66 | $3.13 | $2.21 | $2.45 | $2.58 | $2.29 | $3.20 |
| Growth | -19.8% | 17.1% | 41.5% | -9.9% | -5.1% | 12.6% | -28.4% | -48.6% |
| Diluted EPS [+] | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 | $2.25 | $3.11 |
| Growth | -21.0% | 16.9% | 43.8% | -8.5% | -7.5% | 13.2% | -27.5% | -47.7% |
| |
| Dividends per share [+] | $1.52 | $1.50 | $1.48 | $1.46 | $1.44 | $1.42 | $1.40 | $1.38 |
| Growth | 1.4% | 1.3% | 1.4% | 1.4% | 1.8% | 1.1% | 1.6% | 14.5% |
| |
| Shares outstanding (basic) [+] | 50.2 | 52.3 | 55.5 | 55.2 | 52.8 | 55.4 | 58.0 | 59.1 |
| Growth | -4.0% | -5.8% | 0.6% | 4.5% | -4.7% | -4.5% | -1.8% | 0.8% |
| Shares outstanding (diluted) [+] | 51.4 | 52.8 | 55.9 | 56.5 | 54.9 | 56.1 | 59.1 | 60.9 |
| Growth | -2.5% | -5.7% | -1.0% | 3.0% | -2.2% | -5.0% | -3.0% | -0.9% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|